Bluejay Reconciled Depreciation from 2010 to 2024

BJDX Stock  USD 3.52  0.02  0.57%   
Bluejay Diagnostics Reconciled Depreciation yearly trend continues to be fairly stable with very little volatility. Reconciled Depreciation is likely to outpace its year average in 2024. During the period from 2010 to 2024, Bluejay Diagnostics Reconciled Depreciation regression line of annual values had r-squared of  0.43 and arithmetic mean of  244,378. View All Fundamentals
 
Reconciled Depreciation  
First Reported
2010-12-31
Previous Quarter
793.6 K
Current Value
833.2 K
Quarterly Volatility
234.9 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Bluejay Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bluejay Diagnostics' main balance sheet or income statement drivers, such as Net Interest Income of 173.1 K, Depreciation And Amortization of 820 K or Interest Expense of 22.8 K, as well as many indicators such as Price To Sales Ratio of 1.2 K, Dividend Yield of 0.0 or PTB Ratio of 24.26. Bluejay financial statements analysis is a perfect complement when working with Bluejay Diagnostics Valuation or Volatility modules.
  
Check out the analysis of Bluejay Diagnostics Correlation against competitors.
For more information on how to buy Bluejay Stock please use our How to Invest in Bluejay Diagnostics guide.

Latest Bluejay Diagnostics' Reconciled Depreciation Growth Pattern

Below is the plot of the Reconciled Depreciation of Bluejay Diagnostics over the last few years. It is Bluejay Diagnostics' Reconciled Depreciation historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Bluejay Diagnostics' overall financial position and show how it may be relating to other accounts over time.
Reconciled Depreciation10 Years Trend
Slightly volatile
   Reconciled Depreciation   
       Timeline  

Bluejay Reconciled Depreciation Regression Statistics

Arithmetic Mean244,378
Geometric Mean191,094
Coefficient Of Variation96.11
Mean Deviation160,004
Median142,975
Standard Deviation234,883
Sample Variance55.2B
Range690.3K
R-Value0.65
Mean Square Error34.1B
R-Squared0.43
Significance0.01
Slope34,305
Total Sum of Squares772.4B

Bluejay Reconciled Depreciation History

2024833.2 K
2023793.6 K
2022306.4 K
2021145.7 K
2020157 K

About Bluejay Diagnostics Financial Statements

Bluejay Diagnostics investors use historical fundamental indicators, such as Bluejay Diagnostics' Reconciled Depreciation, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Bluejay Diagnostics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Reconciled Depreciation793.6 K833.2 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Bluejay Stock Analysis

When running Bluejay Diagnostics' price analysis, check to measure Bluejay Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bluejay Diagnostics is operating at the current time. Most of Bluejay Diagnostics' value examination focuses on studying past and present price action to predict the probability of Bluejay Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bluejay Diagnostics' price. Additionally, you may evaluate how the addition of Bluejay Diagnostics to your portfolios can decrease your overall portfolio volatility.